slotkoers
INDONESIA S.E.
00:00:00 26-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
496
IDR
|
0,00%
|
|
-0,80%
|
-22,50%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
2.360.400
|
903.000
|
1.423.800
|
928.200
|
575.400
|
537.600
|
Bedrijfswaarde
1 |
3.082.348
|
1.812.324
|
2.286.442
|
1.710.711
|
1.271.196
|
1.274.339
|
K/w-verhouding
|
17,8
x
|
8,85
x
|
29,4
x
|
83,8
x
|
20,5
x
|
90,2
x
|
Dividendrendement
|
5,6%
|
7,91%
|
1,36%
|
0,71%
|
1,95%
|
-
|
Marktkapitalisatie/omzet
|
2,31
x
|
0,82
x
|
1,45
x
|
0,88
x
|
0,49
x
|
0,53
x
|
Bedrijfswaarde/omzet
|
3,01
x
|
1,64
x
|
2,33
x
|
1,63
x
|
1,09
x
|
1,26
x
|
Bedrijfswaarde/EBITDA
|
14,6
x
|
8,6
x
|
22,1
x
|
12,5
x
|
8,02
x
|
13,9
x
|
Bedrijfswaarde/FCF
|
-12,5
x
|
-16,4
x
|
16,6
x
|
17,3
x
|
11,9
x
|
-26,4
x
|
FCF Yield
|
-8,01%
|
-6,08%
|
6,03%
|
5,77%
|
8,41%
|
-3,78%
|
Price to Book
|
3,07
x
|
1,13
x
|
1,98
x
|
1,29
x
|
0,77
x
|
0,72
x
|
Aantal aandelen (in duizenden)
|
840.000
|
840.000
|
840.000
|
840.000
|
840.000
|
840.000
|
Referentieprijs
2 |
2.810
|
1.075
|
1.695
|
1.105
|
685,0
|
640,0
|
Datum van publicatie
|
20/02/19
|
31/03/20
|
6/05/21
|
29/04/22
|
29/03/23
|
6/04/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
1.022.970
|
1.105.420
|
980.557
|
1.051.444
|
1.168.474
|
1.014.130
|
EBITDA
1 |
211.624
|
210.740
|
103.311
|
137.392
|
158.576
|
91.959
|
Bedrijfsresultaat (EBIT)
1 |
186.585
|
168.904
|
60.253
|
94.725
|
117.549
|
53.490
|
Operationele Marge
|
18,24%
|
15,28%
|
6,14%
|
9,01%
|
10,06%
|
5,27%
|
Resultaat voor belastingen (EBT)
1 |
177.570
|
129.657
|
64.083
|
12.892
|
41.502
|
7.662
|
Nettowinst (verlies)
1 |
132.307
|
102.034
|
48.488
|
11.071
|
28.070
|
5.959
|
Nettomarge
|
12,93%
|
9,23%
|
4,94%
|
1,05%
|
2,4%
|
0,59%
|
WPA
2 |
157,5
|
121,5
|
57,72
|
13,18
|
33,42
|
7,094
|
Free Cash Flow
1 |
-246.772
|
-110.257
|
137.769
|
98.758
|
106.960
|
-48.228
|
FCF-marge
|
-24,12%
|
-9,97%
|
14,05%
|
9,39%
|
9,15%
|
-4,76%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
133,35%
|
71,88%
|
67,45%
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
284,13%
|
892,05%
|
381,05%
|
-
|
Dividend per aandeel
2 |
157,5
|
85,03
|
23,09
|
7,900
|
13,37
|
-
|
Datum van publicatie
|
20/02/19
|
31/03/20
|
6/05/21
|
29/04/22
|
29/03/23
|
6/04/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
721.948
|
909.324
|
862.642
|
782.511
|
695.796
|
736.739
|
Nettokaspositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
3,411
x
|
4,315
x
|
8,35
x
|
5,695
x
|
4,388
x
|
8,012
x
|
Free Cash Flow
1 |
-246.772
|
-110.257
|
137.769
|
98.758
|
106.960
|
-48.228
|
ROE (netto-inkomsten/eigen vermogen)
|
17,9%
|
12,7%
|
6,23%
|
1,52%
|
3,62%
|
0,78%
|
ROA (netto-inkomsten/totale activa)
|
7,66%
|
5,32%
|
1,88%
|
3,15%
|
4,03%
|
1,87%
|
Totale activa
1 |
1.727.151
|
1.916.375
|
2.583.401
|
351.056
|
696.298
|
318.391
|
Nettoactief per aandeel
2 |
917,0
|
953,0
|
857,0
|
857,0
|
894,0
|
892,0
|
Cashflow per aandeel
2 |
129,0
|
127,0
|
71,70
|
112,0
|
176,0
|
78,40
|
Capex
1 |
83.806
|
30.637
|
26.968
|
7.227
|
10.772
|
13.420
|
Capex/omzet
|
8,19%
|
2,77%
|
2,75%
|
0,69%
|
0,92%
|
1,32%
|
Datum van publicatie
|
20/02/19
|
31/03/20
|
6/05/21
|
29/04/22
|
29/03/23
|
6/04/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -22,50% | 25,68 mln. | | +25,83% | 661 mld. | | +27,00% | 566 mld. | | -6,76% | 352 mld. | | +20,34% | 332 mld. | | +3,00% | 283 mld. | | +13,09% | 231 mld. | | +5,46% | 200 mld. | | -9,61% | 195 mld. | | -6,26% | 145 mld. |
Farmaceutische producten - Andere
|